2-Fluoropyridine-5-boronic acid
Based on 1 Customer Validation
2-Fluoropyridine-5-boronic acid (6-Fluoropyridine-3-boronic acid) is a fatty acid amide hydrolase (FAAH) inhibitor with an IC50 of 10 μM. 2-Fluoropyridine-5-boronic acid is applicable to research related to inflammation and pain.
For research use only. We do not sell to patients.
- CAS No.: 351019-18-6
- Formula: C5H5BFNO2
- Molecular Weight:140.91
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
In Vitro
2-Fluoropyridine-5-boronic acid inhibits FAAH with an IC50 of 10 μM[1].
2-Fluoropyridine-5-boronic acid (100 μM) shows weak MGL inhibition, reducing activity by 2%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 351019-18-6
-
Appearance Solid
-
Molecular Weight 140.91
-
Formula C5H5BFNO2
-
Color White to off-white
-
SMILES
FC1=CC=C(B(O)O)C=N1
-
Synonyms
6-Fluoropyridine-3-boronic acid
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Minkkilä A, et al. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. Journal of medicinal chemistry. 2008 Nov 27;51(22):7057-60. [Content Brief]
[2]. Yang Y, et al. Synthesis, antimosquito activities, photodegradation, and toxic assessment of novel pyrethroids containing 2-chlorobiphenyl and 2-chlorophenylpyridine. Pest management science. 2021 Jun;77(6):2773-2784. [Content Brief]
[3]. Hualong M, et al. Discovery of a Selective and Orally Bioavailable RET Degrader with Effectiveness in Various Mutations. Journal of medicinal chemistry. 2025 Feb 13;68(3):2657-2679. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)